| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Translation factors 0.5644414591261101 3.1517152925581633 0.0016231445396728 0.6202264429978415 0.3189795603709919 37 Q13144,P63241,O43432,P23588,P29692,Q15056,O75153,P62495,P05198,P11940,Q14240,Q9H074,P55010,O15372,P60842,Q04637,P49770 17 |
| Proteasome degradation 0.5240144398839357 2.879140625861058 0.0039876048087426 0.907575538108442 0.3189795603709919 42 P28074,P25787,Q15008,Q13200,P28070,O00231,P25789,P28072,P49720,P49721,P61289,P25788,O43242,P51665,Q99436,P46934,P20618,P60900,P17980 19 |
| Angiopoietinlike protein 8 regulatory pathway 0.532347739039035 2.685852542074317 0.0072345008938656 0.9867986329615548 0.3189795603709919 32 P49327,Q15382,Q16539,P28482,P49841,P27361,O14654,P31751,P49815,P41440,P31749,P22681,P51812,Q6R327 14 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.719817664675652 2.679061886338233 0.0073828747269095 0.9879237765964998 0.3189795603709919 13 P49841,P27361,P31751,P49815,Q05086,P31749,Q15382 7 |
| Thyroid hormones production and peripheral downstream signaling effects 0.6357364307547626 2.6052300716458214 0.0091812585340784 0.9959021997359668 0.3189795603709919 18 P49841,Q16539,Q7LBC6,Q9UNY4,P49815,P62993,O60343,Q15382 8 |
| Mecp2 and associated rett syndrome 0.5832173863463866 2.5788853505281426 0.0099119677723673 0.9973600765154694 0.3189795603709919 23 Q00013,Q03518,P52597,P67809,P35637,Q05086,P16220 7 |
| Glycogen synthesis and degradation 0.6485807672337489 2.567144939879702 0.010253974199184 0.9978513539574896 0.3189795603709919 16 P49841,P35573,P46976,P63151,Q15257,P30153,P06737,P30154,P52789,P0DP25 10 |
| Translation inhibitors in chronically activated pdgfra cells 0.6017753273109102 2.5173453811498065 0.0118242855502932 0.999165994077938 0.3189795603709919 20 Q16539,O43432,P23588,P27361,P31751,Q53EL6,Q14240,P31749,P60842,Q04637 10 |
| Circadian rhythm genes 0.46575393378647 2.424586973478627 0.0153258118036416 0.9998994546507256 0.3367303423171886 47 P49841,Q9Y297,Q03164,Q9UNS1,P43490,Q96EB6,P00813,Q05086,P16220 9 |
| Regulation of actin cytoskeleton 0.4740695495653284 2.3748412763694406 0.0175564979387976 0.9999739792153248 0.3367303423171886 39 P28482,P46940,P27361,Q16512,O96013,P61586,Q96F07,P35580,Q9UBI6,P15311,P60953,P41240,P18206,Q92888,P07737,Q02750,Q9UQB8,P35241,Q9NSV4,O60610,Q8TBX8,P25054,P12814 23 |
| Melanoma 0.6169494029313822 2.3724079497298303 0.0176725660839025 0.9999757484955994 0.3367303423171886 16 Q00534,P28482,Q07812,P11802,P27361,Q16512,P31751,P62993,P0DP25,P31749,P16220,P18206 12 |
| Tnfalpha signaling pathway 0.5688915197124245 2.363986293441687 0.0180794814666946 0.9999810549468356 0.3367303423171886 21 Q6GQQ9,Q9Y297,P27361,Q16543,P06737,P62993,Q9NR28,P07900,P31749,Q13200 10 |
| Acute viral myocarditis 0.638446726628373 2.308301845084615 0.0209823538970226 0.9999967554852232 0.3526468566869296 14 P49841,P28482,P09874,P27361,Q9NRG0,P11940,P31749,P16220,Q04637 9 |
| Pi3kaktmtor signaling pathway and therapeutic opportunities 0.7744888439894977 2.2955126286541185 0.0217037635207275 0.9999979090283548 0.3526468566869296 7 P49841,Q15382,P49815,Q6R327 4 |
| Follicle stimulating hormone fsh signaling pathway 0.7045472812788425 2.294463679370739 0.0217638790253746 0.999997984224426 0.3526468566869296 10 Q16539,P27361,P49815,P31749,P16220,Q15382 6 |
| Retinoblastoma gene in cancer 0.4496686077142195 2.264432726407147 0.0235475130417153 0.9999993206946096 0.3526468566869296 47 P06493,P23921,Q07864,P11802,P16949,Q14566,P20248,Q16204,P52701,P09884,P33991,P35244,O95067,P31350,P33993,Q9NQW6,P26583,P15927,Q9UNN5,P25205,P09429,P26358,Q00534,P27694,P00374,P24941 26 |
| Il4 signaling pathway 0.670016512813363 2.2430245307080794 0.0248952326743363 0.9999997017621796 0.3526468566869296 11 P29353,Q16539,P28482,P27361,P62993,P31749,P22681 7 |
| Target of rapamycin tor signaling 0.6418198184338675 2.241235650365219 0.0250108147291741 0.9999997221055428 0.3526468566869296 13 Q6R327,P62942,P49815,Q15382 4 |
| Cardiac hypertrophic response 0.6369736499184903 2.213325567937652 0.0268752081172767 0.9999999111928216 0.3526468566869296 13 P49841,Q16539,P27361,P31751,Q08209,P31749,P50750 7 |
| Pi3kakt signaling pathway 0.451380546347308 2.2125251268639783 0.0269304020135623 0.999999914144773 0.3526468566869296 43 P28482,P11802,P27361,P31751,P62993,P30154,P07942,P23588,Q9UBI6,P49815,P30153,P07900,P16220,Q15382,P49841,Q00534,P63151,Q16543,Q16513,Q14738,P31749,P08238 22 |
| Tcell activation sarscov2 0.5912024391755623 2.210849445555745 0.0270462644841567 0.9999999200266788 0.3526468566869296 16 Q6R327,P49841,P27361,P49815,P62993,P31749,Q15382 7 |
| Wnt signaling pathway 0.6204118234741886 2.2016431017956912 0.0276905287934277 0.9999999461120505 0.3526468566869296 14 P49841,Q00534,P25054,P28482,P49815,O14641,P48729,P31749 8 |
| G1 to s cell cycle control 0.5045318021880943 2.1647982803320507 0.030403136576969 0.9999999898057252 0.3526468566869296 27 Q13416,P06493,P33993,Q07864,Q00534,P11802,P49643,Q9UBD5,Q14566,P33991,P15927,P25205,O43913,P35244,P16220,P24941 16 |
| Genes related to primary cilium development based on crispr 0.5985884785214122 2.160123924383241 0.0307630774051812 0.9999999918294704 0.3526468566869296 15 Q8WXW3,O95684,Q8NCM8,Q7Z4L5 4 |
| Embryonic stem cell pluripotency pathways 0.6271160418376645 2.15630119720723 0.0310601538551844 0.9999999931938376 0.3526468566869296 13 P49841,P28482,P31751,O14641,P62993,P25054,P31749 7 |
| Physicochemical features and toxicityassociated pathways 0.5244607662360575 2.1530369628763437 0.0313157736971245 0.999999994184222 0.3526468566869296 23 P35080,P29353,P49841,P61160,P28482,Q14012,Q16512,P07197,P19174,P07737,P62993,P31749,P25054,P61586,P22681,P07196 16 |
| Pancreatic adenocarcinoma pathway 0.5285713168296322 2.1491452822544272 0.0316228851766899 0.9999999951857084 0.3526468566869296 22 Q00534,P42224,P28482,Q07812,P11802,P27361,Q16512,P31751,P11233,Q02750,O96013,P31749,P60953,P61586 14 |
| Nad biosynthetic pathways 0.8287914691943072 2.139741691763944 0.0323756477228123 0.9999999969713668 0.3526468566869296 5 P09874,P43490,Q8IXJ6,Q96EB6 4 |
| Ranklrank signaling pathway 0.5785469720446388 2.1304484918333473 0.0331346039840068 0.9999999981026552 0.3526468566869296 16 Q13501,P42224,Q16539,P28482,P27361,P31751,P19174,P31749,P22681 9 |
| Tnfrelated weak inducer of apoptosis tweak signaling pathway 0.6684620896690163 2.105416911002433 0.0352550330138834 0.9999999994873006 0.3686315732679742 10 P49841,Q16539,P27361,P31751,P31749 5 |
| Micrornas in cardiomyocyte hypertrophy 0.5397379989998412 2.0933311929581753 0.0363195999757777 0.9999999997344884 0.3732151997510952 20 Q13144,P49841,Q16539,P27361,P31751,Q08209,P31749,P50750 8 |
| Insulin signaling 0.4328517743616074 2.0770234161137178 0.0377993980625732 0.999999999893754 0.3818379872083672 46 Q16539,P28482,P27361,P31751,Q6ZWJ1,P62993,O60343,P41440,P51812,P29353,Q9H4M9,P49815,P10586,P46976,P33176,Q12965,P22681,Q15382,P49841,O14654,P31749 21 |
| Malignant pleural mesothelioma 0.3712224440990641 2.042295124941925 0.0411222653977765 0.9999999999864828 0.407892483398341 72 Q16539,P28482,Q15047,P11802,P27361,P31751,P62993,P07942,O96013,P51812,P29353,Q9Y297,P23588,P49815,Q9HCK8,O14641,P16220,Q15382,P49841,P09429,P25054,P31749,Q04637,Q13257 24 |
| Cytosine methylation 0.8026861482730603 2.0293371673653855 0.0424239601103479 0.9999999999939844 0.407892483398341 5 P48735 1 |
| Bdnftrkb signaling 0.615323214657358 2.010961835757743 0.0443294880038596 0.9999999999981648 0.407892483398341 12 P29353,P28482,P49815,P62993,P31749,P16220,Q15382 7 |
| Nocgmppkg mediated neuroprotection 0.6925037405803086 2.0055323106036793 0.0449061701145132 0.9999999999987194 0.407892483398341 8 P16220,Q99996,P07196 3 |
| Nad metabolism 0.8560852827953755 1.9789978503050147 0.0478162482965265 0.9999999999997924 0.407892483398341 4 P43490,Q8IXJ6,Q96EB6 3 |
| Spinal cord injury 0.5145995245467883 1.9789321946396627 0.0478236409095467 0.9999999999997932 0.407892483398341 21 P08670,P06493,P04083,P28482,P11802,P27361,P62942,P14174,Q08209,P24941 10 |
| Pdgf pathway 0.5530100297847801 1.9662832903029748 0.0492658959166889 0.9999999999999162 0.407892483398341 16 P29353,P42224,P28482,P27361,Q16512,P19174,P62993,P60953,P00403,P61586,P53365 11 |
| Tcell receptor tcr signaling pathway 0.5123573612084679 1.9627355894974527 0.0496769054827612 0.9999999999999352 0.407892483398341 21 P08670,P29353,P49327,Q16539,P28482,P27361,Q16512,P19174,P62993,P60953,P31749,P22681,P16220 13 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.5649493360261139 1.9508357511185823 0.0510765874963925 0.9999999999999732 0.407892483398341 15 P49841,P55209,P11802,Q9UPY3,P50402,P25054 6 |
| Regulatory circuits of the stat3 signaling pathway 0.6153269637991245 1.9407683754205012 0.0522863785300784 0.9999999999999876 0.407892483398341 11 Q16539,P28482,Q13263,P27361,Q8WTS6,Q6R327 6 |
| Ciliopathies 0.5065729253299192 1.9208496187112176 0.054750668912529 0.9999999999999972 0.407892483398341 21 Q8TD19,Q7Z4L5,Q9ULC3,Q15555,Q9BW83,O43924,Q9UBB4,Q01968,Q8WXW3,Q8NCM8,Q2M1P5 11 |
| Epo receptor signaling 0.6936811604988846 1.9134467903307408 0.0556908791970598 0.9999999999999986 0.408585293431576 7 P29353,P28482,P27361,P62993,P31749 5 |
| 1q211 copy number variation syndrome 0.6315235123593977 1.9079673346840984 0.0563954383305547 0.999999999999999 0.408585293431576 10 Q9NPH0,Q16625 2 |
| Chemokine signaling pathway 0.4865329010683113 1.8688735378921328 0.0616404106870382 1.0 0.4237530627747436 23 P29353,P49841,P42224,P28482,P27361,Q16512,P31751,Q9UBI6,P62993,P60953,P31749,P41240 12 |
| Resistin as a regulator of inflammation 0.6841359546962981 1.8673224565336304 0.0618565712439642 1.0 0.4237530627747436 7 Q16539,P28482,P27361,P31751,P31749 5 |
| Glioblastoma signaling pathways 0.5064949474819703 1.8589399370783424 0.0630356524245521 1.0 0.4256415928528749 20 Q00534,P28482,P52701,P11802,P27361,P31751,P49815,P62993,P31749,P22681,P24941 11 |
| Nonsmall cell lung cancer 0.5497993287518002 1.85524972814803 0.0635605734293722 1.0 0.4256415928528749 15 Q00534,P28482,Q07812,P11802,P27361,P31751,P19174,P28702,P62993,P31749 10 |
| Tgfbeta signaling in thyroid cells for epithelialmesenchymal transition 0.7575359105493249 1.835533894169877 0.0664266217979649 1.0 0.4398918510176348 5 P08670,P27361,P31749 3 |
| Caloric restriction and aging 0.7552309168570577 1.8255476467272316 0.0679184279229132 1.0 0.4399932939353945 5 P43490 1 |
| Chromosomal and microsatellite instability in colorectal cancer 0.4994707694143769 1.8088322826025995 0.0704770633200704 1.0 0.4425365995671941 20 P49841,P25054,P52701,P28482,Q07812,P27361,P31751,P11233,P43246,P31749,P48729,P61586 12 |
| Ethanol effects on histone modifications 0.5797402691600704 1.8053294350196083 0.0710231461690515 1.0 0.4425365995671941 12 P41440,O94788,Q99707,P00374 4 |
| Egfegfr signaling pathway 0.4024136619758022 1.798951334864993 0.0720263791291397 1.0 0.4425365995671941 48 Q16539,P28482,P46940,Q16512,O14964,P62993,P00403,P51812,Q6R327,P29353,P42224,P20339,P11233,P19174,Q9UBC2,P60953,P41240,Q92888,Q92783,P46934,P22681,P16220,Q96J02,P31749 24 |
| Dna repair pathways full network 0.400329022072916 1.7947879326256484 0.0726874941808217 1.0 0.4425365995671941 49 P09429,Q07864,P52701,Q9UGN5,P09874,Q9BXW9,P18074,P12956,Q9NR33,P35244,Q9UQ84,P41440,P43246,Q9NVI1,P41208 15 |
| Methionine de novo and salvage pathway 0.6676241992491844 1.7870723633611456 0.0739257935910828 1.0 0.4425365995671941 7 Q99707,Q13126 2 |
| Camkk2 pathway 0.5627451952730206 1.7759462207764674 0.0757417816554046 1.0 0.4445368833072751 13 Q13501,P28482,P27361,Q96EB6,O00429,P16220 6 |
| Praderwilli and angelman syndrome 0.6268662790466204 1.7728671039698478 0.0762507307892841 1.0 0.4445368833072751 9 P11802,Q9UIS9,Q7L576,Q15154,Q05086 5 |
| Hypothesized pathways in pathogenesis of cardiovascular disease 0.7409956102831857 1.763687087973581 0.0777846762034997 1.0 0.4445368833072751 5 P27361,Q16539,P28482 3 |
| Wnt signaling pathway and pluripotency 0.5080703095465314 1.7619809309572056 0.0780725193760523 1.0 0.4445368833072751 18 P49841,P63151,P30153,O14641,P30154,P25054 6 |
| Tolllike receptor signaling pathway 0.5772323870229181 1.72495837342158 0.0845349745254033 1.0 0.4445368833072751 11 Q16539,P28482,P27361,P31751,P31749 5 |
| Alzheimers disease 0.3669055457504286 1.7101921160975486 0.0872303531072993 1.0 0.4445368833072751 87 P28482,P28074,P27361,P31751,Q13564,O00213,P25787,Q15008,Q13200,P28070,P25789,P28072,P49720,P49721,P62191,Q9H0B6,P05198,P0DP25,P25788,O43242,P51665,P49327,Q99436,P14735,O14641,P33176,P20618,P49841,P60900,O00487,O14654,P17980,Q08209,P25054,P31749 35 |
| Oncostatin m signaling pathway 0.4997708018603969 1.7049170474166142 0.0882098964850643 1.0 0.4445368833072751 18 P29353,Q16539,P28482,P42224,P27361,P62993,P31749,P16220,Q6R327 9 |
| Influence of laminopathies on wnt signaling 0.5737162440408694 1.704841735266761 0.0882239453731483 1.0 0.4445368833072751 11 P49841,Q00534,Q9UPY3,O60725,P50402,P25054 6 |
| Brainderived neurotrophic factor bdnf signaling pathway 0.3883086556592486 1.7046368823273643 0.0882621682018887 1.0 0.4445368833072751 51 Q13501,P29353,P49841,Q16539,P28482,Q96S59,P10586,Q7L576,P27361,Q96P70,P67809,P49815,P62993,P05198,P25054,P31749,P16220,P51812 18 |
| Corticotropinreleasing hormone signaling pathway 0.499617426048126 1.7038604014300054 0.088407170417134 1.0 0.4445368833072751 18 P49841,Q16539,P28482,Q13263,P09874,P27361,P42892,P19174,P31749,P07900,P61586,P16220 12 |
| Ccl18 signaling pathway 0.613155259310674 1.7006299847122224 0.0890124899950335 1.0 0.4445368833072751 9 P08670,P00403,P33176,P07196 4 |
| 15q112 copy number variation syndrome 0.7856157591254135 1.691602928374346 0.0907217077796336 1.0 0.4445368833072751 4 Q7L576,Q06787 2 |
| Pi3kaktmtor vitd3 signaling 0.6896925501905964 1.6853634994005635 0.0919184613535186 1.0 0.4445368833072751 6 P49841,P49815 2 |
| Mfap5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement 0.6433156902418407 1.6679244623179696 0.0953307228994926 1.0 0.4445368833072751 7 P28482,P12814,P27361,P19174,P16220 5 |
| T cell receptor and costimulatory signaling 0.7188981042653971 1.667055984563944 0.095503273210469 1.0 0.4445368833072751 5 P49841,P31749,Q08209,P19174 4 |
| Parkinubiquitin proteasomal system pathway 0.4011182193851337 1.6599892106317031 0.0969166230796323 1.0 0.4445368833072751 36 Q13616,P34932,Q15008,Q13200,O00231,Q9UNM6,P62191,P62333,P68371,Q99460,P60604,O43242,P51665,Q0VDF9,P11142,P55036,P07437,Q13885,P54652,O00487,P17980,P22314,P68036,P0DMV9 24 |
| Il9 signaling pathway 0.6841391685547579 1.6597922623113572 0.0969562508990726 1.0 0.4445368833072751 6 P27361,P50750,P28482,P62993 4 |
| Breast cancer pathway 0.4419339709974082 1.659303974754015 0.0970545547473888 1.0 0.4445368833072751 27 P29353,P49841,Q00534,P28482,P11802,P09874,P27361,P31751,O14641,P62993,P25054,P31749 12 |
| Alzheimers disease and mirna effects 0.3641106183027313 1.6562819714319983 0.0976647297367918 1.0 0.4445368833072751 88 P28482,P28074,P27361,P31751,Q13564,O00213,P25787,Q15008,Q13200,P28070,P25789,P28072,P49720,P49721,P62191,Q9H0B6,P05198,P0DP25,P25788,O43242,P51665,P49327,Q99436,P14735,O14641,P33176,P20618,P49841,P60900,O00487,O14654,P17980,Q08209,P25054,P31749 35 |
| Kennedy pathway from sphingolipids 0.6821946344589173 1.6508271155617045 0.0987738816494907 1.0 0.4445368833072751 6 Q9HBU6 1 |
| Erbb signaling pathway 0.4696405235505462 1.6502569940195797 0.0988903842626478 1.0 0.4445368833072751 21 P29353,P49841,P28482,P27361,Q16512,P31751,P19174,Q02750,P62993,P31749,O96013,P22681 12 |
| Netrinunc5b signaling pathway 0.5415836830677738 1.6481564000242634 0.0993205811740836 1.0 0.4445368833072751 13 Q16539,Q8TCG1,P27361,Q15257,P30154,P31749 6 |
| Il7 signaling pathway 0.6808925306337494 1.6448206350227306 0.1000068054720491 1.0 0.4445368833072751 6 P49841,P27361,P28482,P31749 4 |
| Il17 signaling pathway 0.7722830915013285 1.6365306537838429 0.1017285756121002 1.0 0.4445368833072751 4 P49841,P27361,P31749 3 |
| Vitamin a and carotenoid metabolism 0.6788834966208611 1.6355481495710242 0.1019341896655214 1.0 0.4445368833072751 6 P29375,O94788,Q6NUM9,P28482 4 |
| Nucleotide metabolism 0.5614352311423121 1.634341957401486 0.1021870683318515 1.0 0.4445368833072751 11 P30566,P23921,P19623,P00374,P00492,P30520,P28340,P31350 8 |
| Disruption of postsynaptic signaling by cnv 0.6004823818407428 1.6334891562143803 0.1023661595223031 1.0 0.4445368833072751 9 Q7L576,Q14168,Q06787 3 |
| Glutathione metabolism 0.7057158056681448 1.609088723935078 0.1075969425291787 1.0 0.4445368833072751 5 O75874,P28161,P48637 3 |
| Neural crest differentiation 0.5767971093043871 1.6087465116290511 0.1076717809968912 1.0 0.4445368833072751 10 P49841,O14641 2 |
| Kit receptor signaling pathway 0.498526322274441 1.608227423711071 0.1077853790956897 1.0 0.4445368833072751 16 P29353,Q16539,P28482,P42224,P27361,P62993,P31749,P22681,P51812 9 |
| Il2 signaling pathway 0.5562913616727152 1.6047091228334247 0.1085578333219416 1.0 0.4445368833072751 11 P29353,P28482,P27361,P62993,P31749,P22681 6 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.670811779150615 1.5982343753729296 0.1099908260920172 1.0 0.4445368833072751 6 P25054,O14641 2 |
| Sterol regulatory elementbinding proteins srebp signaling 0.4073393428933848 1.5937098939565195 0.1110010271780785 1.0 0.4445368833072751 32 P49327,Q9NR31,Q96EB6,Q15437,P53396,P31749,P48449,O95486,P16220 9 |
| Hepatitis b infection 0.4505355927592881 1.5934653070106908 0.1110558451877361 1.0 0.4445368833072751 23 P49327,Q16539,P28482,P63104,P42224,Q07812,P27361,P31751,Q02750,P27348,P62993,O00571,P31946,P31749,P16220 15 |
| Interferon type i signaling pathways 0.4900768808569969 1.5929085216136691 0.1111807143237877 1.0 0.4445368833072751 17 P60842,P42224,Q16539,P23588,Q53EL6,P22681,P16220 7 |
| Dna mismatch repair 0.469401985914929 1.5923626570957945 0.1113032418140833 1.0 0.4445368833072751 20 P52701,Q9NR33,P35244,P41440,P43246,Q9UQ84 6 |
| Head and neck squamous cell carcinoma 0.4737543553181041 1.5720102048407576 0.115948184577447 1.0 0.444707680093284 19 Q15382,P11802,P31751,P62942,P49815,Q6R327 6 |
| Il6 signaling pathway 0.5288442455488718 1.570678909428452 0.1162572505132575 1.0 0.444707680093284 13 P29353,P49841,P28482,P27361,P62993,P31749 6 |
| Tgfbeta receptor signaling in skeletal dysplasias 0.7562507603601234 1.570064971271424 0.1163999968029401 1.0 0.444707680093284 4 P62942,P27361 2 |
| Tgfbeta receptor signaling 0.7562507603601234 1.570064971271424 0.1163999968029401 1.0 0.444707680093284 4 P62942,P27361 2 |
| Thermogenesis 0.4092504956510486 1.558698829422125 0.1190676789768723 1.0 0.4482322467959113 31 Q16539,Q7LBC6,O43772,P49815,P62993,P16220,Q15382 7 |
| Initiation of transcription and translation elongation at the hiv1 ltr 0.5675542236424252 1.5575282785212428 0.1193451120088231 1.0 0.4482322467959113 10 P50750,O00267,P18615,Q9H3P2 4 |
| Pdgfrbeta pathway 0.601859959007472 1.5473140232656788 0.1217875418506375 1.0 0.4482322467959113 8 P29353,P42224,P27361,P19174,P62993,P19525 6 |
| Aryl hydrocarbon receptor pathway wp2586 0.6181790595139269 1.5435926159712807 0.122687054978261 1.0 0.4482322467959113 7 P28482,O00170,Q16543,P07900,P24941 5 |
| 4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression 0.5989153422780433 1.5321519926068812 0.1254849320865698 1.0 0.4482322467959113 8 Q96KB5,P27361,P31749 3 |
| Histone modifications 0.5814368953721583 1.531973231904052 0.1255290404221918 1.0 0.4482322467959113 9 Q01105,Q8WTS6,Q03164 3 |
| Kisspeptinkisspeptin receptor system in the ovary 0.6561756031543275 1.5303463780365394 0.1259310142202294 1.0 0.4482322467959113 6 P27361,P31751,P31749 3 |
| Endothelin pathways 0.6151096201293319 1.528341372304984 0.1264278028908891 1.0 0.4482322467959113 7 P27708,Q05682,P00403,P42892 4 |
| Mapk cascade 0.6145663409823353 1.5256405312355237 0.127099412262599 1.0 0.4482322467959113 7 P27361,Q16539,P62993 3 |
| Met in type 1 papillary renal cell carcinoma 0.4657752638737444 1.515332086972936 0.1296883264067991 1.0 0.4546720149320724 19 P28482,O43815,P27361,Q16512,P31751,P19174,Q02750,P62993,P31749,P60953,O96013,P22681 12 |
| Nad metabolism sirtuins and aging 0.7385214257619321 1.4962982175431905 0.1345759594068565 1.0 0.4690483731373479 4 P43490,Q96EB6 2 |
| Neural crest cell migration during development 0.590748887449531 1.4900314207441734 0.1362159744550384 1.0 0.4706754511156032 8 P61586,Q16512,P31751,P31749,O96013 5 |
| Agerage pathway 0.4616842054177064 1.486217292544926 0.1372216549809164 1.0 0.4706754511156032 19 P29353,Q16539,P28482,P42224,P27361,O60610,P15311,P60953,P31749,P61586 10 |
| 16p112 proximal deletion syndrome 0.4245966991870534 1.4807928141618854 0.138661791972511 1.0 0.4706754511156032 26 Q16204,Q6IN85,P30153,Q9NY27,P15311,P78318 6 |
| Myometrial relaxation and contraction pathways 0.4455793175603983 1.4715777134739616 0.1411349474842229 1.0 0.4752340604553496 21 Q05682,P63104,Q99439,Q9UBI6,P19174,P78417,Q9Y3B8,Q04917,P16220,P31946,P0DP25,P10644 12 |
| Tcell antigen receptor tcr pathway during staphylococcus aureus infection 0.4889681130649017 1.4644636325366849 0.143067312762974 1.0 0.4790343730715309 15 P49841,P11802,P27361,Q16512,P19174,P62993,P31749,P22681 8 |
| Serotonin htr1 group and fos pathway 0.5836812387914521 1.4535000469397266 0.1460849666670831 1.0 0.4864058108021316 8 Q16539,P28482,P27361,P61586,P16220 5 |
| Hepatitis c and hepatocellular carcinoma 0.547914810413609 1.4481779752554014 0.1475672825865936 1.0 0.4886116690089435 10 Q16539,P27361,P62993,P31749,P31350 5 |
| Il5 signaling pathway 0.5179218882142168 1.440066687427819 0.1498485327721064 1.0 0.4889628713887906 12 P49841,P29353,P28482,P27361,P62993,P31749 6 |
| B cell receptor signaling pathway 0.4331968999609769 1.4346592565807197 0.1513842198365949 1.0 0.4889628713887906 22 P29353,P49841,Q16539,P28482,P19174,P62993,P31749,P22681,P16220 9 |
| Mirna regulation of dna damage response 0.4227828280989892 1.4338840336080805 0.1516053589094355 1.0 0.4889628713887906 25 P06493,P33993,P11802,Q9BXW9,Q9Y3B8,P41440,P16220,O95067 8 |
| Estrogen signaling pathway 0.5961168514067079 1.433688000131352 0.1516613181132671 1.0 0.4889628713887906 7 P31749,Q16539,P16220 3 |
| Angiogenesis 0.7219425525614378 1.4271158951400882 0.1535464915765043 1.0 0.4893781228855446 4 P31749,Q16539,P28482 3 |
| Mfap5mediated ovarian cancer cell motility and invasiveness 0.7219425525614375 1.4271158951400866 0.1535464915765048 1.0 0.4893781228855446 4 P27361,P16220,P28482 3 |
| Prostaglandin and leukotriene metabolism in senescence 0.927789286771234 1.4109182343388686 0.1582687249004619 1.0 0.4990907938660069 2 Q96EB6 1 |
| Egfr tyrosine kinase inhibitor resistance 0.4799197942619263 1.4056164130192963 0.1598380596107977 1.0 0.499880245737059 15 P29353,P49841,P28482,Q07812,P27361,P31751,P19174,P62993,P31749 9 |
| Fragile x syndrome 0.3661963373925635 1.4044109175832975 0.1601965217043259 1.0 0.499880245737059 47 P28482,P46821,Q14012,Q9UPY3,P62993,Q96F07,Q9Y4R8,P50570,P29353,Q06787,P19174,P49815,P16220,Q15382,Q9NQX3,Q7L576,Q08209,P31749,P60842,Q04637 20 |
| Striated muscle contraction pathway 0.5893923942382553 1.4000739009842695 0.1614911895981583 1.0 0.5012955677109499 7 P08670,P06753,P09493,P35609,P67936 5 |
| Focal adhesion pi3kaktmtorsignaling pathway 0.3689440967438103 1.389202980375155 0.1647710356985814 1.0 0.5039141953559566 43 P49841,P23588,P27361,O14654,P31751,Q9UBI6,Q16543,P30153,P49815,P62993,P31749,P30154,P07900,P07942,P16220,Q15382 16 |
| Adipogenesis 0.4881267725328268 1.38659845901137 0.1655642384814881 1.0 0.5039141953559566 14 P14174,P43490 2 |
| Leptin signaling pathway 0.3899173366440066 1.386041636029984 0.1657341902027935 1.0 0.5039141953559566 31 P29353,Q07666,Q16539,P28482,P42224,Q07812,P49841,P27361,P19174,Q02750,O75116,P62993,P31749,P60953,P61586,P16220,O00629,P62753 18 |
| Androgen receptor signaling pathway 0.3944083953092072 1.3805813009429546 0.1674077360410728 1.0 0.5039141953559566 30 P49841,Q86X55,Q96EB6,Q05086,P31749,P16220,Q9UBS8 7 |
| Congenital generalized lipodystrophy cgl 0.9183190292986096 1.3740321267889757 0.1694317088493413 1.0 0.5049064923710371 2 P31751 1 |
| Pathogenic escherichia coli infection 0.4141175194708629 1.364433913912236 0.1724310402451587 1.0 0.5112880596324111 25 P63104,O15144,P60953,P68371,P07437,Q13885,P27348,Q16625,P15311,Q92974,P61586,Q14247 12 |
| Joubert syndrome 0.4439708112445957 1.3598339619537612 0.1738824724968704 1.0 0.5130393742976967 19 Q8TD19,Q9UIS9,P09874,Q15154,O43924,Q8WXW3,P41208,Q15382 8 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.5636693116748651 1.3497350283604523 0.1771009921437123 1.0 0.5159939664303897 8 P31943,P27361,O14964,P28482 4 |
| Interleukin11 signaling pathway 0.4925663036386275 1.3483426161973129 0.1775482112892095 1.0 0.5159939664303897 13 P28482,P27361,Q15257,P62993,P31749,P16220 6 |
| Melatonin metabolism and effects 0.8960923623445824 1.3458699139206909 0.1783444731327648 1.0 0.5159939664303897 3 P42892,Q96EB6 2 |
| Osteoblast differentiation and related diseases 0.5296297372304462 1.345862365759469 0.1783469078601682 1.0 0.5159939664303897 10 P27361,Q16539,P28482 3 |
| Cell migration and invasion through p75ntr 0.6416681814503601 1.32488199487164 0.1852102935621176 1.0 0.525146489395895 5 Q16512,P31751,P31749 3 |
| Erk pathway in huntingtons disease 0.6971662348664558 1.3234897176107356 0.1856725734936604 1.0 0.525146489395895 4 P42858,P16220 2 |
| Wnt signaling 0.467217809769304 1.3228388283935566 0.1858889816567219 1.0 0.525146489395895 15 P49841,Q9HCK8,O14641,Q08209,P25054,P48729 6 |
| Endometrial cancer 0.465677081779852 1.3127891292089282 0.1892540141120982 1.0 0.5284678581869132 15 P49841,P27361,P31751,P62993,P25054,P31749 6 |
| 16p112 distal deletion syndrome 0.5694315910536327 1.3000669791304975 0.1935780139320617 1.0 0.5336834276696633 7 P20339,Q9H2V7,P62993,Q8WWM7 4 |
| Neovascularisation processes 0.6898858201468789 1.2930138149241572 0.1960062810872809 1.0 0.5336834276696633 4 P27361,P31749 2 |
| Interactions between loxl4 and oxidative stress pathway 0.6872946028789257 1.2821665914411828 0.1997842130271734 1.0 0.5385830822908061 4 Q8TAG9,Q96EB6 2 |
| Cannabinoid receptor signaling 0.6028091079257651 1.2809758394845538 0.2002021524823787 1.0 0.5385830822908061 6 P27361,Q16539,P28482,Q8NCG7 4 |
| Cell cycle 0.3436226742302037 1.2533749655251936 0.2100692778367761 1.0 0.5564501759587491 53 P06493,P63104,P11802,Q9UJX4,Q14566,Q9UBD5,Q04917,P33991,Q9UJX2,O95067,P33993,Q9H1A4,O43913,P25205,Q13416,P49841,Q00534,Q9Y3B8,P31946,P24941 20 |
| Map3k1 role in promoting and blocking gonadal determination 0.6227951408991693 1.2406858017029023 0.2147218413897906 1.0 0.5583578994622808 5 P49841,P28482 2 |
| Pyrimidine metabolism 0.3532659496263708 1.2383303698314092 0.2155935873039196 1.0 0.5583578994622808 44 P19388,P23921,Q9H773,Q07864,Q05682,Q9NRF8,P17812,Q9BZX2,Q9NR33,O14802,P27708,P28340,P31350 13 |
| Ras signaling 0.368250145236539 1.2371594996167556 0.2160278740149879 1.0 0.5583578994622808 32 P29353,P55196,P28482,P20339,P27361,Q16512,P31751,P11233,P19174,Q9UBI6,Q02750,O96013,P62993,P31749,P60953,P61586,P0DP25 17 |
| Cohesin complex cornelia de lange syndrome 0.4263719613622058 1.2340198868500003 0.2171954938973852 1.0 0.5583578994622808 19 P06493,Q7Z5K2,P30153,P30154,P25054 5 |
| Insulin signaling in adipocytes diabetic condition 0.6737033820428469 1.2252846957973675 0.2204679726037612 1.0 0.5592583010003875 4 P31751 1 |
| Insulin signaling in adipocytes normal condition 0.6737033820428469 1.2252846957973675 0.2204679726037612 1.0 0.5592583010003875 4 P31751 1 |
| Serotonin receptor 467 and nr3c signaling 0.6736748593426024 1.22516536638151 0.2205129206964615 1.0 0.5592583010003875 4 P27361,P16220,P28482 3 |
| Cellular proteostasis 0.6730304357564021 1.2224693839177367 0.2215301748619316 1.0 0.5594575602445392 4 O15212 1 |
| Mesodermal commitment pathway 0.4291960256277248 1.2132724894099824 0.2250256573415503 1.0 0.5610241141233023 18 P42858,Q9BV73,Q16204,Q8N3C0 4 |
| Lipid metabolism pathway 0.4888406440181864 1.212166688641627 0.2254485799904817 1.0 0.5610241141233023 11 P49327,P53396,P31751 3 |
| Dna damage response 0.397923624193167 1.208604075816516 0.2268149897982281 1.0 0.5610241141233023 24 P06493,P49327,Q00534,P11802,Q9BXW9,Q9Y3B8,P15927,P41440,P16220,O95067 10 |
| Il1 signaling pathway 0.4600024884718613 1.2084946139648312 0.2268570662814024 1.0 0.5610241141233023 14 P61088,Q13501,Q16539,P28482,P27361,P31749 6 |
| Il3 signaling pathway 0.4672314453525922 1.1923047554027693 0.233141770585751 1.0 0.5741838647483786 13 P29353,P28482,P27361,Q02750,P31946,P62993,P31749,P22681 8 |
| Disorders of folate metabolism and transport 0.5288609242038447 1.168610530247035 0.2425605836790445 1.0 0.5818010643703804 8 P00374 1 |
| Neuroinflammation 0.65927866753357 1.164980310379699 0.2440269629557161 1.0 0.5818010643703804 4 Q16539 1 |
| Aryl hydrocarbon receptor pathway wp2873 0.540494135969136 1.1548305084709054 0.2481598410499095 1.0 0.5818010643703804 7 P07900,Q16543,O00170,Q15185 4 |
| Oxidative damage response 0.6033813522403841 1.1541122080101591 0.2484541689777417 1.0 0.5818010643703804 5 O95429 1 |
| Rac1pak1p38mmp2 pathway 0.4253155890848247 1.1497318847361409 0.2502543176132552 1.0 0.5818010643703804 17 Q16539,P28482,Q16512,P27361,P43246,P16949,P62993,P31749 8 |
| Regucalcin in proximal tubule epithelial kidney cells 0.573025066863531 1.1413276939184516 0.2537335817115962 1.0 0.5818010643703804 6 P31749,P28482,Q8NE86 3 |
| Neurodegeneration with brain iron accumulation nbia subtypes pathway 0.4762164749877481 1.1383830341248935 0.2549605752756574 1.0 0.5818010643703804 11 P49815 1 |
| Metabolism of spingolipids in er and golgi apparatus 0.5991863804826985 1.1354275877843658 0.2561962060598328 1.0 0.5818010643703804 5 Q16739 1 |
| Thyroid stimulating hormone tsh signaling pathway 0.4176071296887664 1.1322566756528962 0.2575265387611392 1.0 0.5818010643703804 18 Q16539,P28482,P42224,P11802,Q9UNY4,P27361,P31749,P16220 8 |
| Prolactin signaling pathway 0.3994502423109681 1.1270361887122653 0.2597271807066219 1.0 0.5818010643703804 21 P29353,P49841,Q16539,P28482,P63104,P42224,Q16512,P27361,P62993,P31749,P22681 11 |
| Mirna regulation of prostate cancer signaling pathways 0.534607926478172 1.125310149117004 0.2604576304924118 1.0 0.5818010643703804 7 P49841,P62993 2 |
| Nitric oxide metabolism in cystic fibrosis 0.6459324584141548 1.1093025679075763 0.2672996776938066 1.0 0.5835553403132188 4 O60678,Q86X55 2 |
| Kallmann syndrome 0.6427610036708503 1.0960952286987578 0.2730371024585545 1.0 0.5874733323656984 4 P31749,P62993 2 |
| Ncrnas involved in wnt signaling in hepatocellular carcinoma 0.450529553018461 1.0895669066281186 0.27590396739012 1.0 0.590164174934409 13 P25054,O14641 2 |
| Alpha 6 beta 4 signaling pathway 0.4503111652457984 1.0882259673484254 0.2764953638009197 1.0 0.590164174934409 13 Q16539,P28482,P27361,P62993,P07942,P31749 6 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.588148732926278 1.0863312328108232 0.2773324736635643 1.0 0.590164174934409 5 P49841,P31749,Q07812 3 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.4826215507623564 1.0820309990132555 0.2792387539119183 1.0 0.590164174934409 10 P49841,P31749,Q6R327 3 |
| Fgfr3 signaling in chondrocyte proliferation and terminal differentiation 0.5582113767984828 1.0720263660596905 0.2837081898134952 1.0 0.5936371812047596 6 P27361,Q16539,P28482 3 |
| Relationship between inflammation cox2 and egfr 0.5551600639431787 1.057779097282053 0.290156164571143 1.0 0.6046610981972071 6 P27361,P31751,P31749 3 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.4442273586575717 1.0509069443596857 0.2933013306677017 1.0 0.6090856901670739 13 Q14152,Q13347,P20042,P55884,P60228,P05198,O00303,P55010,O75822,O15372 10 |
| Nanomaterial induced apoptosis 0.5780034238651339 1.041317331298726 0.2977282956616149 1.0 0.6140119371398306 5 P49327,O95831,Q9NR28 3 |
| Nucleotide excision repair 0.3784903651121117 1.035112212878137 0.3006165096644806 1.0 0.6140119371398306 23 P41440,Q9NR33,P18074,P35244 4 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.3734835874480998 1.0167293855710688 0.3092821825331857 1.0 0.6159744925057724 24 Q15392 1 |
| Purine metabolism 0.4992792102162106 1.0149732775068263 0.3101185658323806 1.0 0.6159744925057724 8 P00813,P30566,P30520,P00492 4 |
| Hostpathogen interaction of human coronaviruses apoptosis 0.6191886289606052 0.9983276624468468 0.3181204980439973 1.0 0.6211070954521163 4 P31749,Q16539,Q07812 3 |
| Hostpathogen interaction of human coronaviruses mapk signaling 0.4955155123147833 0.9955083894745697 0.3194890660068146 1.0 0.6211070954521163 8 P27361,Q16539,P51812 3 |
| Dna damage response only atm dependent 0.3815660161860607 0.9943426830697204 0.3200560623043309 1.0 0.6211070954521163 21 P09429,P31751,O14641,P62993,P25054 5 |
| Tgfbeta signaling pathway 0.3316491840566261 0.9933414759494033 0.3205435715611751 1.0 0.6211070954521163 38 P06493,Q9Y297,Q16539,P28482,Q7Z3T8,Q92905,O14964,P62993,P31749,O95067,Q96J02 11 |
| Folatealcohol and cancer pathway hypotheses 0.7991274482606789 0.9924566672158563 0.3209748077168655 1.0 0.6211070954521163 3 P16220 1 |
| Mapk signaling pathway 0.3291407331767014 0.9712031543719876 0.3314471234098763 1.0 0.6340420046887052 39 Q9H2K8,P49327,Q16539,P27361,P31751,Q9UBI6,P62993,P54652,Q08209,P31749,P51812 11 |
| Mirna biogenesis 0.6120985415739001 0.9690961960661012 0.33249719546586 1.0 0.6340420046887052 4 Q9UPY3 1 |
| Leptininsulin signaling overlap 0.8126664693696379 0.9681320296922756 0.332978435348263 1.0 0.6340420046887052 2 O14654 1 |
| Osteopontin signaling 0.6108972460763906 0.9641531832259362 0.3349691322516666 1.0 0.6358012828725901 4 Q02750,P27361,P28482 3 |
| Monoamine transport 0.6051578256547466 0.9405793578509372 0.3469204642840937 1.0 0.6526280419658761 4 P49815 1 |
| Microtubule cytoskeleton regulation 0.3830734909231398 0.926625174956882 0.3541211792515348 1.0 0.6580024483760479 19 P06493,P49841,Q15691,P46821,Q16512,O60610,P16949,P60953,P25054,P31749 10 |
| Interleukin1 induced activation of nfkb 0.8014205386208961 0.9261001498629444 0.354393936121999 1.0 0.6580024483760479 2 Q13501 1 |
| Fluoropyrimidine activity 0.4313427582459255 0.9226159862440366 0.3562073617624697 1.0 0.659315489473391 12 Q99808,P31350,Q9BZX2,P18074,P00374 5 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.6002322064843479 0.9204078124964814 0.3573596875704425 1.0 0.6594005380556773 4 P07099 1 |
| Purine metabolism and related disorders 0.4220026559560303 0.9154476335754738 0.3599566816332378 1.0 0.6621425378191659 13 P30566,Q06203,O15067,P00813,P00492,P07741,P30520 7 |
| Vitamin d in inflammatory diseases 0.5926709039376451 0.8895608591587659 0.373701730936173 1.0 0.6811199744280095 4 Q16539 1 |
| Fibrin complement receptor 3 signaling pathway 0.5901687888658477 0.8793873411625491 0.3791912934296122 1.0 0.6869240452402702 4 P61586,O15111,P31749 3 |
| Dna replication 0.3282681016733084 0.8763054290860299 0.3808640144049524 1.0 0.6878634926828837 32 Q13416,P33993,Q07864,P49643,Q9UBD5,P09884,Q14566,P33991,P15927,O43913,P41440,P25205,P28340,P35244,P24941 15 |
| Wntbetacatenin signaling pathway in leukemia 0.5141509849238278 0.8679471504515944 0.3854232652368283 1.0 0.690745788845824 6 P25054,P31749,P49841 3 |
| Somatroph axis gh and its relationship to dietary restriction and aging 0.7631749857851584 0.8648961436151532 0.3870957944203108 1.0 0.690745788845824 3 Q96EB6 1 |
| Nrp1triggered signaling pathways in pancreatic cancer 0.4203566038186226 0.8580273838149612 0.3908773426909453 1.0 0.6933419531065578 12 P28482,P27361,P31751,O14646,P31749 5 |
| Apoptosis modulation by hsp70 0.7818881325836072 0.853988070360241 0.3931115993726006 1.0 0.6952359442910089 2 P49327 1 |
| Network map of sarscov2 signaling pathway 0.340130896926315 0.8474418519794693 0.3967488850771747 1.0 0.6964545715413863 28 P06493,Q15382,P42224,Q9UGN5,Q96AX1,Q96J02,Q14240,P31749,O95067,P31350 10 |
| Reninangiotensinaldosterone system raas 0.5816663415860623 0.8449553287029925 0.3981357808702244 1.0 0.6964545715413863 4 P16220 1 |
| Serotonin and anxiety 0.7750813850251581 0.8291595305173848 0.4070141415534256 1.0 0.7051756638541908 2 Q06787 1 |
| Nanoparticlemediated activation of receptor signaling 0.4744053570811016 0.826579255474839 0.4084755792765309 1.0 0.705656363040036 7 P62993,Q16539,P28482,Q9Y490 4 |
| Ampactivated protein kinase ampk signaling 0.3727784173653327 0.8231980370386348 0.410395384979193 1.0 0.7069238423341013 18 P49815 1 |
| G13 signaling pathway 0.3792433636791507 0.8118635500807767 0.4168699316573481 1.0 0.7139496530683317 16 Q92888 1 |
| Metapathway biotransformation phase i and ii 0.3502279767940301 0.8056194091730792 0.4204623308002237 1.0 0.7179558938425094 22 Q9GZZ1,P48637,P07099,Q86UY6,Q16850,P28161,O43708 7 |
| Gastrin signaling pathway 0.331394036765741 0.8036166677057913 0.4216183940350306 1.0 0.7179558938425094 29 P29353,P49841,Q16539,P28482,Q16512,P27361,P19174,P62993,P31749,P60953,P61586,P16220 12 |
| Integrinmediated cell adhesion 0.3423078913611632 0.7773046318413974 0.4369790629696934 1.0 0.7377890128326836 24 P29353,P28482,Q16512,Q15942,P31751,Q02750,P62993,Q9Y490,P60953,P31749,O96013,P41240,P18206 13 |
| Apoptosis 0.4093892452534443 0.7537983432249642 0.4509703189755556 1.0 0.7486861005833737 11 P49327,P31749,Q9NR28 3 |
| P38 mapk signaling pathway 0.4052148935606751 0.730486071144864 0.4650931239897158 1.0 0.7637925649584496 11 P29353,Q16539,P42224,P62993,P16220 5 |
| Thymic stromal lymphopoietin tslp signaling pathway 0.3965662792307806 0.7205634519900489 0.4711781471265905 1.0 0.7697334930511366 12 P42224,Q16539,P28482,Q9BTU6,P27361,Q02750,P31749 7 |
| Dna irdamage and cellular response via atr 0.3018416965057178 0.7131303862490523 0.4757650780930942 1.0 0.7747431326324704 37 P06493,P33993,Q13263,P09874,Q92900,Q9BXW9,P39748,Q92547,O94782,P13010,P15927,O43324,P24941,P43246,Q9NVI1,Q9UQ84,P46063 17 |
| Neural crest cell migration in cancer 0.4266788573767283 0.7039053859832908 0.4814916970847847 1.0 0.7798072050612274 9 P61586,Q16512,P31751,P31749,O96013 5 |
| Methionine metabolism leading to sulfur amino acids and related disorders 0.4968156450460309 0.690194460641896 0.4900719063895546 1.0 0.7857109379487647 5 Q99707,P55263 2 |
| Mbdnf and probdnf regulation of gaba neurotransmission 0.435146115190514 0.6896565711394171 0.4904101827465443 1.0 0.7857109379487647 8 P29353,P61586,P16220,P19174 4 |
| Intraflagellar transport proteins binding to dynein 0.4327803900338818 0.6780467937126105 0.4977420243080039 1.0 0.7953196956771323 8 Q8NCM8,Q13409 2 |
| Pyrimidine metabolism and related diseases 0.4410730270772179 0.666840095878899 0.5048742782677662 1.0 0.8024135195935698 7 Q05682,P27708,P31350 3 |
| Energy metabolism 0.3718812790656357 0.6626943107096495 0.5075263542602038 1.0 0.8033188892425115 14 Q16539,P16220,Q96EB6 3 |
| Il10 antiinflammatory signaling pathway 0.7034764491855424 0.6617372414854648 0.5081396329604477 1.0 0.8033188892425115 3 P53004 1 |
| Nonhomologous end joining 0.7007397454535013 0.6527726259067198 0.5139028737140303 1.0 0.8094831839768052 3 P12956 1 |
| Base excision repair 0.3464963875012761 0.6492844303636918 0.5161545475104066 1.0 0.8094831839768052 18 P09429,Q07864,Q9NR33,P09874 4 |
| Exrna mechanism of action and biogenesis 0.6970594353633366 0.6407746012842279 0.5216691369464088 1.0 0.8094831839768052 3 Q9UPY3 1 |
| Photodynamic therapyinduced ap1 survival signaling 0.4139927000225414 0.6392753622376545 0.5226438133864078 1.0 0.8094831839768052 9 P07900,P49327,P20248,Q16539 4 |
| Lncrna in canonical wnt signaling and colorectal cancer 0.3482306752054573 0.6365837635462555 0.5243960039063889 1.0 0.8094831839768052 17 P25054,P61978,O14641 3 |
| G protein signaling pathways 0.3475359131161175 0.6322107338311327 0.5272491843129015 1.0 0.809898231573426 17 Q92888 1 |
| Mir517 relationship with arcn1 and usp1 0.7179638946433894 0.6287879860970673 0.529487866293834 1.0 0.8112461910311699 2 O94782 1 |
| Bile acids synthesis and enterohepatic circulation 0.5222487118163386 0.6125887761317648 0.5401482814799654 1.0 0.8193788240730695 4 P27361,P51114 2 |
| Nad metabolism in oncogeneinduced senescence and mitochondrial dysfunctionassociated senescence 0.3606223036023235 0.5971048762956453 0.550437362466881 1.0 0.8242730352519123 14 P43490,Q8IXJ6 2 |
| Immune response to tuberculosis 0.6758261565972873 0.5729378124301122 0.5666868011088686 1.0 0.8418896824828239 3 Q03518 1 |
| Atr signaling 0.7007990529742567 0.5720525169221052 0.5672863963114947 1.0 0.8418896824828239 2 Q92547 1 |
| Mapk pathway in congenital thyroid cancer 0.6734754292480748 0.5655828928126849 0.5716773598432063 1.0 0.8418896824828239 3 P29353,P27361 2 |
| Serotonin receptor 2 and elksrfgata4 signaling 0.6734754292480728 0.5655828928126797 0.5716773598432099 1.0 0.8418896824828239 3 P27361,P28482 2 |
| Pregnane x receptor pathway 0.5082352459987004 0.5606633074561641 0.5750270853210826 1.0 0.8418896824828239 4 Q99615 1 |
| Integrated cancer pathway 0.3454200761225135 0.552065503856654 0.5809034752751485 1.0 0.8418896824828239 15 P06493,P42224,P52701,P11802,P43246,P31749 6 |
| Physiological and pathological hypertrophy of the heart 0.4418068128123791 0.5496127192377077 0.5825850329775517 1.0 0.8418896824828239 6 Q08209,Q16539,P28482 3 |
| Autophagy 0.4146413752222898 0.5456161824399711 0.5853297982862546 1.0 0.8425994539054631 7 Q8N122,Q13131,Q96B36,P42345,P54619,Q7Z3C6 6 |
| Amyotrophic lateral sclerosis als 0.3706519855383278 0.5436107636199619 0.5867093512932335 1.0 0.8425994539054631 11 Q08209,Q16539,P07197,P07196 4 |
| Epithelial to mesenchymal transition in colorectal cancer 0.3050516697250204 0.535941939936041 0.5919986776429418 1.0 0.8461180140891925 26 P29353,P49841,Q16539,P28482,P27361,P31751,P62993,Q16625,P31749 9 |
| Focal adhesion 0.2782109493814396 0.5048508274357495 0.6136636133248361 1.0 0.8690206002102424 38 P29353,P49841,P28482,P27361,Q16512,P31751,Q15942,O60610,P60953,Q02750,O96013,P62993,Q9Y490,P07942,P31749,P61586,P12814,P18206 18 |
| 3q29 copy number variation syndrome 0.3438121274509705 0.5025037093916502 0.615313243773024 1.0 0.8690206002102424 14 O95684,Q8NCM8 2 |
| Extracellular vesiclemediated signaling in recipient cells 0.4296092064356722 0.4996128517016008 0.6173477068156752 1.0 0.8692843325467696 6 P25054 1 |
| Burn wound healing 0.3839079108282739 0.4918637789828782 0.6228156455182838 1.0 0.872201568825259 9 P08670,P09429,P31749,Q99439 4 |
| Hedgehog signaling pathway wp4249 0.427474166012502 0.4910101875432622 0.6234192421469134 1.0 0.872201568825259 6 P48729,Q2M1P5,Q9Y496 3 |
| Cardiac progenitor differentiation 0.6439562702966318 0.4762055063368799 0.6339279770248698 1.0 0.8827595194084636 3 Q16539 1 |
| Transsulfuration pathway 0.3982225218518205 0.4736853852945445 0.6357242766537932 1.0 0.8831973633698386 7 Q99707 1 |
| Parkinsons disease pathway 0.3950433335653955 0.4601130553818583 0.6454350736531307 1.0 0.8944832231649773 7 P60604,Q16539,P68036 3 |
| Nongenomic actions of 125 dihydroxyvitamin d3 0.3744794186354539 0.4478094616812171 0.6542907143081178 1.0 0.9005941471769936 9 P27361,Q16539,P28482 3 |
| Ebsteinbarr virus lmp1 signaling 0.6303741341705069 0.437127530934608 0.6620188622274941 1.0 0.9091318937501992 3 P07900 1 |
| Nephrotic syndrome 0.3128875362303241 0.4250771377572797 0.6707804434913831 1.0 0.9148401471873326 17 Q27J81,Q6P4I2,P35579,Q7Z4L5 4 |
| Tca cycle nutrient use and invasiveness of ovarian cancer 0.6200302310727512 0.4083268035386404 0.6830337636304524 1.0 0.921013853221153 3 P27361 1 |
| Onecarbon metabolism and related pathways 0.3308911232080302 0.4010757189813358 0.6883643770079542 1.0 0.9260898093256668 13 Q9HBU6 1 |
| Sphingolipid metabolism in senescence 0.3362711079997907 0.3989828634532494 0.6899058311083828 1.0 0.9260898093256668 12 Q06136,Q16739,Q96G23 3 |
| Sphingolipid pathway 0.3521120103324877 0.3949837261657134 0.692854898192186 1.0 0.9279584703877368 10 Q06136,Q16739 2 |
| Endoderm differentiation 0.2787183704227085 0.3845602320371591 0.7005632625488749 1.0 0.9361787095944608 28 Q86VP6,Q9BV73,Q8N3C0,P11940,P25054,Q8IWS0 6 |
| Small cell lung cancer 0.3234667680697776 0.3646461047667217 0.7153755944204956 1.0 0.9423691415147848 13 Q00534,P11802,P31751,P28702,P07942,P31749,P24941 7 |
| Nucleotide excision repair in xeroderma pigmentosum 0.2618082721211661 0.3612224791241708 0.7179331391087445 1.0 0.9423691415147848 33 P09874,P18074,Q9NR33,P41440,P35244,P41208 6 |
| Leukocyteintrinsic hippo pathway functions 0.3915618549292883 0.3541672178230376 0.7232135697683917 1.0 0.9423691415147848 6 P61586,Q16539,P27348,Q13043 4 |
| Heme biosynthesis 0.4067066177579773 0.347708091126844 0.7280594195657963 1.0 0.9423691415147848 5 P06132 1 |
| Apoptosis modulation and signaling 0.3239758327265673 0.3407923731344937 0.7332598925004801 1.0 0.9423691415147848 12 P49327,P27361,Q9NR28 3 |
| Measles virus infection 0.2835560083945699 0.3345841243711333 0.7379388222668457 1.0 0.9423691415147848 21 P49327,Q00534,P42224,O15111,Q07812,P11802,P11142,P05198,P24941,P54652,P0DMV9,P19525,O15372,P67870 14 |
| Tolllike receptor signaling related to myd88 0.5899940793368941 0.3298674513932312 0.7415001182154706 1.0 0.9431065057413632 3 P28482,O15111 2 |
| Mapk and nfkb signaling pathways inhibited by yersinia yopj 0.610535661438301 0.3121699298157105 0.7549113835210002 1.0 0.952709585714802 2 P28482 1 |
| Bladder cancer 0.3915102520604094 0.2988179563218548 0.7650789494089816 1.0 0.9607773130253486 5 P28482,P11802 2 |
| Transcription factors regulate mirnas related to cardiac hypertrophy 0.56880388960628 0.27959016744443 0.779791951615221 1.0 0.968690053619194 3 P31751 1 |
| Hostpathogen interaction of human coronaviruses interferon induction 0.3850746883420439 0.2791195722485255 0.7801530633174716 1.0 0.968690053619194 5 Q16539,P42224 2 |
| Canonical nfkb pathway 0.5898194732169342 0.2638371716057573 0.7919053902945108 1.0 0.9771751813986096 2 O15111 1 |
| Photodynamic therapyinduced nfkb survival signaling 0.5898194732169342 0.2638371716057573 0.7919053902945108 1.0 0.9771751813986096 2 O15111 1 |
| Common pathways underlying drug addiction 0.3413019465888617 0.2530171173108027 0.8002549857730457 1.0 0.9813826574500724 7 P27361,P16220 2 |
| Vitamin d receptor pathway 0.3027121776254216 0.2484284911302244 0.8038028916482496 1.0 0.983709493680404 12 P11413,P09493,Q92783,P24941 4 |
| S1p receptor signal transduction 0.3295876611654956 0.2334060247843944 0.8154461352616651 1.0 0.9906082463699776 8 P27361,P31751,P31749 3 |
| Rala downstream regulated genes 0.4022849788352037 0.22918589402091 0.8187244357645433 1.0 0.9906082463699776 4 P11233 1 |
| Sleep regulation 0.4001731963364199 0.2240031183814958 0.822754876771479 1.0 0.9910915901736168 4 P00813 1 |
| Robo4 and vegf signaling pathways crosstalk 0.5652559928973133 0.2129124397657348 0.8313952593121643 1.0 0.9946534729739788 2 P63000 1 |
| Overview of nanoparticle effects 0.53700414446419 0.2128194232380783 0.8314678132233955 1.0 0.9946534729739788 3 Q6P4R8,Q07812 2 |
| Cysteine and methionine catabolism 0.3436505138255412 0.2008289712192476 0.8408323086598459 1.0 0.9962943458474516 6 Q99707,P48637 2 |
| Sulfation biotransformation reaction 0.5202286738761536 0.1820295698178421 0.855559520196489 1.0 1.0 3 P11413 1 |
| Vasopressinregulated water reabsorption 0.2604896572919862 0.1807070405850092 0.8565975321852424 1.0 1.0 18 Q8NCM8,P16220,Q13409 3 |
| Proteoglycan biosynthesis 0.3742967130589224 0.1659587739622779 0.8681893938018153 1.0 1.0 4 Q8WVQ1,Q9NX62,Q8NCH0 3 |
| Srebf and mir33 in cholesterol and lipid homeostasis 0.3111311307592318 0.1599283399505317 0.8729375237932477 1.0 1.0 7 Q96EB6 1 |
| Ras and bradykinin pathways in covid19 0.3646709417344754 0.1470112161031018 0.8831231673429205 1.0 1.0 4 P28482 1 |
| Interleukin1 il1 structural pathway 0.2937175661758788 0.1353632133422904 0.8923247078877841 1.0 1.0 9 P27361,Q16539 2 |
| Foxa2 pathway 0.4889330918350437 0.1330115854338099 0.8941842180647912 1.0 1.0 3 P28161 1 |
| Peroxiredoxin 2 induced ovarian failure 0.4721264985206326 0.1111845035811739 0.9114700397881874 1.0 1.0 3 Q9UGN5 1 |
| Clear cell renal cell carcinoma pathways 0.2195571737957517 0.1065505991292836 0.9151455115619912 1.0 1.0 38 Q13501,P49327,P53396,P49815,P52789,P14618,Q15382 7 |
| Notch signaling pathway 0.255014900881982 0.0989312932278528 0.9211928223747629 1.0 1.0 13 P49841,Q13642,Q96J02 3 |
| Hijack of ubiquitination by sarscov2 0.3278772400310515 0.0879697167331405 0.9299007453502453 1.0 1.0 4 Q13564 1 |
| Exerciseinduced circadian regulation 0.2397657421524126 0.0819576932203058 0.9346803561449928 1.0 1.0 15 P31689,Q00577,P11142,Q13185,P25789,Q96PU8 6 |
| Phosphoinositides metabolism 0.2716146306053224 0.0762659562030479 0.9392075099484 1.0 1.0 9 Q8TBX8,Q13614,P19174 3 |
| Envelope proteins and their potential roles in edmd physiopathology 0.2298964285330954 0.0719888215098284 0.94261080391255 1.0 1.0 17 Q14739,P28482,P27361,P33176,P62993,P50402,P61586 7 |
| Mammary gland development pathway pregnancy and lactation stage 3 of 4 0.2842119798888636 0.0700375997708719 0.9441637328123929 1.0 1.0 6 P61201 1 |
| Metastatic brain tumor 0.4197001774289274 0.0618896475634312 0.9506507117421112 1.0 1.0 3 Q00534 1 |
| Eukaryotic transcription initiation 0.2245848733712198 0.0558371236397341 0.9554715606749784 1.0 1.0 16 Q15545,P29083,P13984,P18074 4 |
| Pentose phosphate metabolism 0.2784360189573431 0.0552882910055772 0.955908790322749 1.0 1.0 5 P11413,O95336,P52209,P29401 4 |
| Ddx1 as a regulatory component of the drosha microprocessor 0.2692535545023655 0.0452981227291611 0.9638696837493388 1.0 1.0 5 P49959,Q92499,Q8WYQ5,Q92878 4 |
| Hippoyap signaling pathway 0.388099467140323 0.0440142138032337 0.9648930738710446 1.0 1.0 3 P27348,Q13043 2 |
| Purinergic signaling 0.3915359573838481 0.0420625297999654 0.9664488506069344 1.0 1.0 2 P08754 1 |
| Photodynamic therapyinduced hif1 survival signaling 0.2432512607534929 0.0341266192528601 0.9727761817500185 1.0 1.0 10 P00338,Q07812,P53985,Q07820,P08559,P17858,P14618,P00558,P04637 9 |
| Hypertrophy model 0.3345174659561867 0.0281073256291042 0.9775765513759822 1.0 1.0 3 P20248,P06730 2 |
| Angiotensin ii receptor type 1 pathway 0.3315571343990463 0.0276092384660883 0.9779738132450028 1.0 1.0 3 P63244,P28482 2 |
| Biomarkers for pyrimidine metabolism disorders 0.2384073667374981 0.0191756742287533 0.9847009631881388 1.0 1.0 7 P31350 1 |
| Atm signaling pathway 0.2085091798396569 0.0156809424606885 0.9874889308424252 1.0 1.0 15 P06493,P16220 2 |
| Hepatocyte growth factor receptor signaling 0.2312339575840118 0.0015554711870116 0.9987589140555756 1.0 1.0 9 P27361,Q16512,P28482,P62993 4 |
|
|
